annual total liabilities:
$61.40M-$12.39M(-16.80%)Summary
- As of today (August 20, 2025), DYN annual total liabilities is $61.40 million, with the most recent change of -$12.39 million (-16.80%) on December 31, 2024.
- During the last 3 years, DYN annual total liabilities has risen by +$3.93 million (+6.84%).
- DYN annual total liabilities is now -16.80% below its all-time high of $73.79 million, reached on December 31, 2023.
Performance
DYN Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$157.55M+$105.45M(+202.39%)Summary
- As of today (August 20, 2025), DYN quarterly total liabilities is $157.55 million, with the most recent change of +$105.45 million (+202.39%) on June 30, 2025.
- Over the past year, DYN quarterly total liabilities has increased by +$106.86 million (+210.80%).
- DYN quarterly total liabilities is now at all-time high.
Performance
DYN quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
DYN Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.8% | +210.8% |
| 3 y3 years | +6.8% | +197.4% |
| 5 y5 years | +2458.2% | +1002.5% |
DYN Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -16.8% | +13.8% | at high | +256.3% |
| 5 y | 5-year | -16.8% | +2458.2% | at high | +1336.6% |
| alltime | all time | -16.8% | +2458.2% | at high | +6464.5% |
DYN Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $157.55M(+202.4%) |
| Mar 2025 | - | $52.10M(-15.1%) |
| Dec 2024 | $61.40M(-16.8%) | $61.40M(-3.0%) |
| Sep 2024 | - | $63.30M(+24.9%) |
| Jun 2024 | - | $50.69M(+14.6%) |
| Mar 2024 | - | $44.22M(-40.1%) |
| Dec 2023 | $73.79M(+36.7%) | $73.79M(+38.7%) |
| Sep 2023 | - | $53.21M(+19.4%) |
| Jun 2023 | - | $44.54M(-4.6%) |
| Mar 2023 | - | $46.71M(-13.4%) |
| Dec 2022 | $53.96M | $53.96M(+8.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $49.94M(-5.7%) |
| Jun 2022 | - | $52.97M(+3.2%) |
| Mar 2022 | - | $51.30M(-10.7%) |
| Dec 2021 | $57.47M(+424.0%) | $57.47M(+8.9%) |
| Sep 2021 | - | $52.76M(+262.6%) |
| Jun 2021 | - | $14.55M(+8.2%) |
| Mar 2021 | - | $13.45M(+22.6%) |
| Dec 2020 | $10.97M(+357.0%) | $10.97M(-25.0%) |
| Sep 2020 | - | $14.63M(+2.4%) |
| Jun 2020 | - | $14.29M(+495.4%) |
| Dec 2019 | $2.40M(-41.3%) | $2.40M |
| Dec 2018 | $4.09M | - |
FAQ
- What is Dyne Therapeutics, Inc. annual total liabilities?
- What is the all time high annual total liabilities for Dyne Therapeutics, Inc.?
- What is Dyne Therapeutics, Inc. annual total liabilities year-on-year change?
- What is Dyne Therapeutics, Inc. quarterly total liabilities?
- What is the all time high quarterly total liabilities for Dyne Therapeutics, Inc.?
- What is Dyne Therapeutics, Inc. quarterly total liabilities year-on-year change?
What is Dyne Therapeutics, Inc. annual total liabilities?
The current annual total liabilities of DYN is $61.40M
What is the all time high annual total liabilities for Dyne Therapeutics, Inc.?
Dyne Therapeutics, Inc. all-time high annual total liabilities is $73.79M
What is Dyne Therapeutics, Inc. annual total liabilities year-on-year change?
Over the past year, DYN annual total liabilities has changed by -$12.39M (-16.80%)
What is Dyne Therapeutics, Inc. quarterly total liabilities?
The current quarterly total liabilities of DYN is $157.55M
What is the all time high quarterly total liabilities for Dyne Therapeutics, Inc.?
Dyne Therapeutics, Inc. all-time high quarterly total liabilities is $157.55M
What is Dyne Therapeutics, Inc. quarterly total liabilities year-on-year change?
Over the past year, DYN quarterly total liabilities has changed by +$106.86M (+210.80%)